Biomarker potential of nuclear Nrf2 activation in the ABC subtype of diffuse large B‑cell lymphoma.

Oncol Lett · 2025 · PMC11542154 · PMID 39512504

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a marked trendno p-value reported

Additionally, there was a marked trend towards lower WBC and platelet counts in the nuclear Nrf2-positive group compared with that of the nuclear Nrf2-negative group, whilst higher levels of GOT and GPT were observed in the nuclear Nrf2-positive group compared with that of the nuclear Nrf2-negative group.

also in 422 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.